---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-016538"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2026-05-13T12:03:45+00:00"
generated_at: "2026-05-13T12:07:08.054392+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Reviva Pharmaceuticals to be delisted from Nasdaq May 14, 2026; will trade on OTCQB

## Summary
- Nasdaq Hearings Panel determined to delist RVPH due to non-compliance with minimum $1.00 bid price rule.
- Trading on Nasdaq suspended as of May 14, 2026; stock will quote on OTCQB Venture Market under same symbol RVPH.
- Delisting risks include reduced liquidity, fewer investors, penny stock classification, and limited analyst coverage.
- Company updated risk factors to reflect additional risks of OTC trading vs. national exchange listing.

## SEC filing metadata
- accession: 0001437749-26-016538
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2026-05-13T12:03:45+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774926016538/0001437749-26-016538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774926016538/rvph20260512_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-016538
- JSON: https://secwatch.observer/filing/0001437749-26-016538.json
- Plain text: https://secwatch.observer/filing/0001437749-26-016538.txt

## Key facts
- Listing & Compliance Notices
  REVIVA PHARMACEUTICALS HOLDINGS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: May 12, 2026 indicating that the Panel had determined to delist the Company’s common stock from Nasdaq. The Company’s common stock will be suspended from trading on Nasdaq as of the open of trading on May 14, 2026. Begin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1742927/000143774926016538/0001437749-26-016538-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.